Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Norepinephrine
Drug ID BADD_D01583
Description Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.
Indications and Usage Mainly used to treat patients in vasodilatory shock states such as septic shock and neurogenic shock and has shown a survival benefit over dopamine. Also used as a vasopressor medication for patients with critical hypotension.
Marketing Status Prescription; Discontinued
ATC Code C01CA03
DrugBank ID DB00368
KEGG ID D00076
MeSH ID D009638
PubChem ID 439260
TTD Drug ID D07MOX
NDC Product Code 44911-0282; 43857-0161; 43742-0951; 43742-1319; 43857-0260; 63083-1530
Synonyms Norepinephrine | Levonorepinephrine | Noradrenaline | Levarterenol | Levophed | Levophed Bitartrate | Noradrénaline tartrate renaudin | Norepinephrine Bitartrate | Norepinephrine l-Tartrate (1:1) | Noradrenaline Bitartrate | Norepinephrine d-Tartrate (1:1) | Norepinephrin d-Tartrate (1:1) | Norepinephrine Hydrochloride | Norepinephrine Hydrochloride, (+)-Isomer | Norepinephrine Hydrochloride, (+,-)-Isomer | Norepinephrine l-Tartrate (1:1), (+,-)-Isomer | Norepinephrine l-Tartrate (1:1), Monohydrate | Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer | Norepinephrine l-Tartrate (1:2) | Norepinephrine l-Tartrate, (+)-Isomer | Norepinephrine, (+)-Isomer | Norepinephrine, (+,-)-Isomer | Arterenol | Levonor
Chemical Information
Molecular Formula C8H11NO3
CAS Registry Number 51-41-2
SMILES C1=CC(=C(C=C1C(CN)O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Aggression19.05.01.001--Not Available
Anaphylactic shock10.01.07.002; 24.06.02.0040.000371%Not Available
Anxiety19.06.02.0020.000371%
Arrhythmia02.03.02.001--Not Available
Blood pressure decreased13.14.03.0020.000742%Not Available
Blood pressure increased13.14.03.0050.000371%Not Available
Blood pressure systolic decreased13.14.03.0070.000371%Not Available
Bradycardia02.03.02.002--Not Available
Cardiac arrest02.03.04.0010.000194%
Cardiogenic shock24.06.02.006; 02.05.01.0030.000556%Not Available
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
Compartment syndrome24.04.05.006; 15.05.05.0050.000097%Not Available
Cyanosis24.03.01.007; 22.02.02.007; 02.01.02.0020.000742%
Disseminated intravascular coagulation24.01.01.010; 01.01.02.0020.000097%
Drug hypersensitivity10.01.01.0010.000371%Not Available
Dyspnoea22.02.01.004; 02.01.03.0020.000556%
Extravasation08.01.03.0080.000742%Not Available
Gangrene23.06.06.001; 11.02.01.003; 24.04.05.003--Not Available
Headache17.14.01.001--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypertension24.08.02.0010.000742%
Hypotension24.06.03.0020.001113%
Hypovolaemia14.05.05.002--Not Available
Injection site necrosis12.07.03.020; 08.02.03.020--Not Available
Lactic acidosis14.01.01.002--Not Available
Myocarditis02.04.03.0010.000097%
Necrosis ischaemic24.04.02.0180.000371%Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.0070.000371%
Pallor24.03.04.001; 23.03.03.031; 08.01.03.032--Not Available
Photophobia17.17.02.006; 06.01.01.004--
The 1th Page    1 2    Next   Last    Total 2 Pages